Pacific Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 05-07-2024
- Paid Up Capital ₹ 0.67 M
as on 05-07-2024
- Company Age 17 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 111.10%
(FY 2022)
- Profit 34.59%
(FY 2022)
- Ebitda -43.01%
(FY 2022)
- Net Worth 9.50%
(FY 2022)
- Total Assets 40.22%
(FY 2022)
About Pacific Meditech
The Corporate was formerly known as Sun Meditech Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.67 M, as per Ministry of Corporate Affairs (MCA) records.
Mayank Aggarwal and Chetan Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24233DL2007PTC171412
- Company No.
171412
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Pacific Meditech Private Limited offer?
Pacific Meditech Private Limited offers a wide range of products and services, including Health Conditions, Pain Relief.
Who are the key members and board of directors at Pacific Meditech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Aggarwal  | Director | 09-Jun-2020 | Current |
| Mayank Aggarwal | Director | 09-Jun-2020 | Current |
Financial Performance of Pacific Meditech.
Pacific Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 111.1% increase. The company also saw a substantial improvement in profitability, with a 34.59% increase in profit. The company's net worth moved up by a moderate rise of 9.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pacific Meditech?
In 2020, Pacific Meditech had a promoter holding of 15.04% and a public holding of 84.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pacific Meditech?
Unlock and access historical data on people associated with Pacific Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pacific Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pacific Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
